though one purely intraductal case has been described.5 These lesions are extremely rare spindle cell tumours requiring a combination of morphology, electron microscopy and/or immunohistological investigations to distinguish them from sarcomas and spindle cell carcinomas. The antibodies most commonly used are CAM 5-2, epithelial membrane antigen (EMA), smooth muscle actin, S100 protein, and glial fibrillary acidic protein (GFAP). These antibodies are not specific for my The mass from the axilla consisted of metastatic deposits in lymph nodes. The tumour was composed of uniform spindle cells with only a mild degree of nuclear pleomorphism (fig 1) and exhibited moderate numbers of mitoses (five per 10 high power fields). In some areas the cells were plump and epithelioid, and appeared to line cleft-like spaces. Foci of necrosis were also seen. The original specimen from 1987 showed some glandular structures but they were present only focally, did not exhibit cytological or structural atypia, and did not show any evidence oftransition with the spindle cell component. They were thus interpreted as entrapped rather than neoplastic structures. There was no evidence of glandular differentiation or in situ tumour in any of the specimens. Sections of all the organs involved at necropsy revealed tumour of identical appearance to that seen in the surgical specimens.
IMMUNOHISTOCHEMISTRY/ IMMUNOFLUORESCENCE
Immunohistology using conventional markers showed that the tumour cells were CAM 5-2, actin and vimentin positive. The immunohistochemical profile ofthe tumour is presented in the table. Staining with a polyspecific anticytokeratin antibody (LP34) showed that at least 75% of the cells in the lesion were keratin positive. All the cells that were keratin positive were also vimentin positive when frozen tumour sections were simultaneously stained with LP34 and an antibody to vimentin.
Three staining patterns were seen using double-labelling immunofluorescence: (i) approximately two thirds of the tumour cells, organised largely in discrete fascicles, were cytokeratin (CK) 14, smooth muscle actin and vimentin positive (figs 2A, 2D, and 2F). These cells were also CK18 and CK19 negative. (ii) The areas with pattern A merged at their edges with less obviously fascicular areas of smooth muscle actin and vimentin positive but CK14 negative cells. These cells accounted for about one quarter of the tumour cells ( fig 2C) . (iii) The remainder of the cells were vimentin positive and smooth muscle actin and CK14 negative. Some of these were interspersed between the cytokeratin positive cell bundles and were almost certainly stromal fibroblasts (figs 2E and 2F). Others appeared to be contiguous with cells showing pattern B and could have been either fibroblasts or tumour cells that had lost both actin and CK14 expression. They represented the least numerically significant component. Hence, over half the cells in this metastatic lesion showed a specific myoepithelial phenotype with concurrent CK14, smooth muscle actin and vimentin positive staining and CK1 8 and CK1 9 negative staining in the same cells.
ELECTRON MICROSCOPY
The tumour cells were spindle shaped ( fig 3A) and joined by well formed desmosomes. The cytoplasm showed plentiful rough endoplasmic reticulum and zones of 6 nM microfilaments with focal densities near the plasma membrane. Keratin filaments were present in many cells ( fig 3B) . Basement membrane-like material was associated with occasional tumour cells which exhibited focal membrane thickening and occasional hemidesmosomes, sometimes in association with pinocytotic vesicles (fig 3C) . 
Discussion
Myoepithelial carcinomas are difficult to diagnose. Unlike adenomyoepitheliomas which exhibit distinctive combined patterns of epithelial and myoepithelial differentiation, they are composed purely of spindle cells and consequently virtually impossible to differentiate from spindle cell carcinomas and sarcomas on morphological examination. It is essential to be able to recognise myoepithelial carcinomas in order to learn more about their natural history and response to treatment. It was interesting to note that tamoxifen had no effect on the tumour in this patient.
To date, immunohistochemistry has been limited to antibodies against smooth muscle actin, S100 protein and GFAP. However, none of these markers on their own are entirely specific for myoepithelial cells or tumours derived from them. Actin may be expressed on tumours exhibiting myofibroblastic or smooth muscle differentiation, and GFAP and S100 on tumours of nerve sheath origin. Combined staining with these antibodies and epithelial markers, however, provides adequate evidence of myoepithelial differentiation for routine diagnostic purposes. Electron microscopy may provide further evidence of myoepithelial differentiation.
Detailed keratin profiles have not previously been reported presumably because of the need for frozen material, the infrequency with which the relevant antibodies are used in routine diagnostic practice and the complexity of the staining procedures. In the present case half of the tumour cells in the lesion showed a very specific myoepithelial phenotype-that is, coexpression of CK14, smooth muscle actin and vimentin in the same cells, which were negative for CK7, 13, 18, and 19. These findings provide further definitive evidence of the truly myoepithelial nature of a small proportion of malignant tumours in the breast.
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